Bal Pharma Limited Share Price and Company Fundamentals

0.900 (0.951%)
52 week
85.25 - 148.85

Last traded: Today at 9:02 AM

Bal Pharma Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers prescription drugs, generics, OTC products, intravenous infusion products, and bulk actives. It provides anti-infectives, pain management, respiratory care, and women's health products under the Aziwin, Ebay, Balvibe, MNF, Ocium, and Monogesic Plus Gel brands; diabetic care products under the Diabend and Diabend M Group brands; herbal/ayurvedic preparations targeting conditions, such as prostrate enlargement, renal calculi, male infertility, women health, etc. under the Stonex, Ashwamed, Prostowin, Suswas, Menoleap, and Ayursulin brands; anti-hypertensive, anti-lipidemic, and anti-obese products; skin care and bone health products; and cardiac care products under the Secremet and Servace brands. The company also offers a range of APIs for therapeutic areas, such as anti-histamine, platelet inhibitor, anti-diabetic, anti convulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, acne treatment, etc.; and various formulations. In addition, it engages in the treatment of gastrointestinal disorders; and piles, fistula, and constipation. The company exports its products to Europe, Latin America, Africa, the Far East, the Middle East, and internationally. Bal Pharma Limited was incorporated in 1987 and is based in Bengaluru, India.

Key Metrics

PE ratio


PB ratio


Dividend yield




Market cap


Enterprise value


Company profile

Industry / SectorDrug Manufacturers—Specialty & Generic / Healthcare
Mailing addressLakshmi Narayan Complex 5th Floor 10/1, Palace Road Bengaluru 560052 India
Phone / Fax91 80 4137 9500 / 91 80 2235 4057


Dividend yield


Dividend amount


Payout ratio


Bal Pharma Limited paid ₹1.00 dividend and the ex-dividend date was 16 Sept 2021.The dividend payout ratio is 26.95%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.BALPHARMA dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

BALPHARMA's forward dividend amount is ₹1 and the forward dividend yield is 1.05%. A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of Jul 2022, following are the company executives and directors listed on Bal Pharma Limited.

NameTitleAgeTotal Pay
Mr. Shailesh Dheerajmal SiroyaMD & Exec. Director5510.2M
Ms. Archana Dubey MitraVP of International Marketing & HR47
Mr. Himesh VirupakshayaWhole Time Director603.05M
Mr. Rengarajan GopalakrishnanChief Financial Officer
Mr. Ravindra Kumar KothariDeputy Gen. Mang. of Internal Audit, Legal and Compliances66
Ms. Preeti SinghCompany Sec. & Compliance officer
Mr. D. L. BhatAssistant VP of Sales & Marketing58
Mr. M. P. GeorgeProduction Advisor

Profitability and management effectiveness

Profit margin


Operating margin


Return on assets


Return on equity


Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Bal Pharma Limited is and its enterprise value is .

The BALPHARMA's stocks Beta value is 0.67 making it 33% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Bal Pharma Limited (NSE:BALPHARMA) Frequently Asked Questions

1. What is Bal Pharma Limited's Stock Symbol?

Bal Pharma Limited trades on NSE under the ticker symbol "BALPHARMA".

2. What is Bal Pharma Limited's stock price today?

One share of BALPHARMA stock can currently be purchased for approximately ₹95.55.

3. How can I contact Bal Pharma Limited?

Bal Pharma Limited's mailing address is Lakshmi Narayan Complex 5th Floor 10/1, Palace Road Bengaluru 560052 India. The company can be reached via phone at 91 80 4137 9500.

4. What is Bal Pharma Limited's official website?

The official website of Bal Pharma Limited is